Correlation Between Biomea Fusion and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Biomea Fusion and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomea Fusion and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomea Fusion and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Biomea Fusion and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomea Fusion with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomea Fusion and Madrigal Pharmaceuticals.
Diversification Opportunities for Biomea Fusion and Madrigal Pharmaceuticals
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Biomea and Madrigal is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Biomea Fusion and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Biomea Fusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomea Fusion are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Biomea Fusion i.e., Biomea Fusion and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Biomea Fusion and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Biomea Fusion is expected to under-perform the Madrigal Pharmaceuticals. In addition to that, Biomea Fusion is 1.43 times more volatile than Madrigal Pharmaceuticals. It trades about -0.25 of its total potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about -0.13 per unit of volatility. If you would invest 33,966 in Madrigal Pharmaceuticals on September 12, 2024 and sell it today you would lose (3,311) from holding Madrigal Pharmaceuticals or give up 9.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomea Fusion vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Biomea Fusion |
| Madrigal Pharmaceuticals |
Biomea Fusion and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomea Fusion and Madrigal Pharmaceuticals
The main advantage of trading using opposite Biomea Fusion and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomea Fusion position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.| Biomea Fusion vs. Edgewise Therapeutics | Biomea Fusion vs. Werewolf Therapeutics | Biomea Fusion vs. Cullinan Oncology LLC | Biomea Fusion vs. Design Therapeutics |
| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |